For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the arrival of Tafamidis and Tafamidis meglumine represents a true advancement . These innovative therapies preserve the transthyretin protein, halting its damaging build-up and lessening the burden of t